Business Context and Reporting Period
This Form 8-K Current Report was filed by Brooks Automation, Inc. (not Azenta, Inc.) on September 4, 2018. The filing reports a corporate governance event: the expansion of the Board of Directors and the appointment of a new director.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to director compensation:
- Annual Board Retainer: $90,000
- Audit Committee Retainer: $10,000
- Restricted Stock Grant Value: $90,000 (annual fair market value, pro-rated for the initial term)
Material Changes
The Board of Directors increased its size from ten to eleven members. Michael Rosenblatt, M.D. was appointed to fill the vacancy and assigned to the Audit Committee. Dr. Rosenblatt brings significant life sciences experience, having served as Chief Medical Officer at Flagship Pioneering and Merck, and previously as Dean of Tufts University School of Medicine.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It confirms there are no undisclosed arrangements or transactions between Dr. Rosenblatt and the Company reportable under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the correct registrant name is Brooks Automation, Inc. (the input metadata incorrectly listed Azenta, Inc.).
- Confirm Dr. Rosenblatt's tenure is effective until the 2019 annual meeting of stockholders.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Note that this filing does not impact the company's financial statements or operational metrics.